|
HOUSTON, June 22, 2018 /PRNewswire/ -- Cellenkos and The University Of Texas Health Science Center at Houston today announce a research collaboration for application of cord blood-derived regulatory T cells (CK0801) as adoptive therapy for treatment of neuroinflammatory disorders. The fir...
Tags
health
center
research
science
Category:
Financial Services
All news |
||||||||||||||||||
|